Stay Informed on Corporate Sustainability

Explore industry news, insights, and updates from the Pharma Industry Awards.

Steris emerges as preferred bidder for Cardinal Health Tullamore facility

Author: Archie Villaflores

United States-based Steris is the preferred bidder to acquire Cardinal Health's Tullamore facility closing in April. The transaction preserves pharmaceutical manufacturing excellence operations in County Offaly and is expected to create new positions.

Ireland's New Medicines Framework Sets a Credible Path to Faster, Fairer Access

Author: Archie Villaflores

Ireland's FASPM 2026-2029 resets medicine pricing and reimbursement rules for the pharmaceutical sector. A new four-year framework between the State, IPHA, and MFI accelerates new medicine access timelines while imposing rigorous pricing discipline across all categories.

Almac Pharma Services claims double honours at the Pharma Industry Awards 2025

Author: Archie Villaflores

Looking back at last year’s highlights, Almac Pharma Services claimed both the Pharma Supplier of the Year and Pharma Facility of the Year awards at the Pharma Industry Awards 2025 for a breadth of achievement that spans cutting-edge facility development, agile expertise, and strategic growth across Ireland's pharmaceutical landscape. The double recognition reflects the high bar the Pharma Industry Awards set for entries across supplier and facility categories as the 2026 cycle approaches.

NIBRT wins Pharma Research Centre of the Year at Pharma Industry Awards 2025

Author: Jed Nykolle Harme

Honoured for world-class research excellence in 2025, the National Institute for Bioprocessing Research and Training won Pharma Research Centre of the Year at the Pharma Industry Awards 2025. The institute's GMP-simulated plant and global policy influence showcase leadership on a national and international scale. NIBRT's achievement sets a global benchmark for bioprocessing innovation, combining cutting-edge discovery with real-world application as the sector looks toward 2026. The recognition underscores the institute's role as a powerhouse of collaboration and sustainability driving industry transformation.

Record Exports, Record Jobs: How Ireland's Pharma Sector Is Redefining National Economic Power

Author: Jed Nykolle Harme

Ireland's pharma sector hit record highs in 2025 for exports, employment and tax receipts. As GLP-1 drug demand surges, the industry's role as Ireland's economic backbone has never been stronger.

Skyhawk Therapeutics appoints Teva veteran Aaron Deves to lead Huntington's disease drug commercialisation

Author: Jed Nykolle Harme

US-based clinical-stage biotech Skyhawk Therapeutics has appointed Aaron Deves as chief commercial officer to lead the commercialisation of SKY-0515 for Huntington's disease. Deves brings over 30 years of neurological drug commercialisation experience.

CF and Medlior join forces to advance cross-border life sciences evidence for UK and Canadian markets

Author: Jed Nykolle Harme

UK consultancy CF has partnered with Canadian firm Medlior Health Outcomes Research to generate real-world evidence for global life science sponsors. The alliance spans NHS England and Alberta datasets.

LifeCellsNI secures £590,000 to establish Northern Ireland's first regulated stem cell biobank in Derry

Author: Jed Nykolle Harme

Derry-based start-up LifeCellsNI has raised £590,000 (€689,000) to build Northern Ireland's first HTA-licensed stem cell storage and biobank facility. Cleanroom installation is under way ahead of an April launch.

Cirdan Imaging targets global expansion with £12.9m investment and 72 new jobs in Northern Ireland

Author: Jed Nykolle Harme

Northern Ireland-based medical imaging firm Cirdan Imaging is creating 72 new jobs in a £12.9m (€15.1m) investment to expand its laboratory information system. Invest NI has offered £1.9m in support towards the initiative.

Athlone Laboratories puts Ireland's critical medicines manufacturing capacity in the spotlight

Author: Jed Nykolle Harme

Irish contract manufacturer Athlone Laboratories has reaffirmed its role in Europe's critical medicines supply chain, with annual capacity to produce 1.2 billion oral Beta-lactam dosage forms. The firm manufactures the antibiotic class at its Irish site for over 40 years.

Discover What's Happening

Women in Pharma Awards 2026

April 29th, 2026

Crowne Plaza Hotel, Santry

Life Sciences Industry Awards 2026

May 28th, 2026

Crowne Plaza Hotel, Santry

Pharma Industry Awards UK 2026

September 23rd, 2026

Park Plaza London Riverbank

Pharma Industry Awards 2025

November 20th, 2025

Dublin Royal Convention Centre

Business Sustainability Updates, Straight to Your Inbox

Explore our newsletters

Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!